Scinai Immunotherapeutics Ltd. (SCNI)
0.4844
+0.04
(+9.84%)
USD |
NASDAQ |
Nov 09, 16:00
0.479
-0.01
(-1.11%)
After-Hours: 19:29
Scinai Immunotherapeutics Max Drawdown (5Y) : 99.98% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.98% |
| September 30, 2026 | 99.97% |
| August 31, 2026 | 99.97% |
| July 31, 2026 | 99.97% |
| June 30, 2026 | 99.97% |
| May 31, 2026 | 99.97% |
| April 30, 2026 | 99.97% |
| March 31, 2026 | 99.97% |
| February 28, 2026 | 99.97% |
| January 31, 2026 | 99.97% |
| December 31, 2025 | 99.97% |
| November 30, 2025 | 99.97% |
| October 31, 2025 | 99.97% |
| September 30, 2025 | 99.97% |
| August 31, 2025 | 99.97% |
| July 31, 2025 | 99.97% |
| June 30, 2025 | 99.96% |
| May 31, 2025 | 99.96% |
| April 30, 2025 | 99.96% |
| March 31, 2025 | 99.95% |
| February 28, 2025 | 99.95% |
| January 31, 2025 | 99.95% |
| December 31, 2024 | 99.95% |
| November 30, 2024 | 99.95% |
| October 31, 2024 | 99.95% |
| Date | Value |
|---|---|
| September 30, 2024 | 99.95% |
| August 31, 2024 | 99.95% |
| July 31, 2024 | 99.95% |
| June 30, 2024 | 99.95% |
| May 31, 2024 | 99.93% |
| April 30, 2024 | 99.91% |
| March 31, 2024 | 99.91% |
| February 29, 2024 | 99.91% |
| January 31, 2024 | 99.91% |
| December 31, 2023 | 99.88% |
| November 30, 2023 | 99.88% |
| October 31, 2023 | 99.88% |
| September 30, 2023 | 99.83% |
| August 31, 2023 | 99.75% |
| July 31, 2023 | 99.74% |
| June 30, 2023 | 99.74% |
| May 31, 2023 | 99.66% |
| April 30, 2023 | 99.66% |
| March 31, 2023 | 99.59% |
| February 28, 2023 | 99.57% |
| January 31, 2023 | 99.49% |
| December 31, 2022 | 99.42% |
| November 30, 2022 | 98.92% |
| October 31, 2022 | 98.92% |
| September 30, 2022 | 98.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Compugen Ltd. | 97.28% |
| Pluri, Inc. | 96.65% |
| Evogene Ltd. | 99.05% |
| CollPlant Biotechnologies Ltd. | 98.79% |
| Regentis Biomaterials Ltd. | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -103.80 |
| Beta (5Y) | 2.268 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 73.49% |
| Historical Sharpe Ratio (5Y) | -1.159 |
| Historical Sortino (5Y) | -1.653 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.41% |